ASCEND-CRC: Adaptive Strategies for Clinical Evolution and Novel Dynamics in Colorectal Cancer
UT MD Anderson Cancer Center (colon cancer): The team will undertake a novel two-phase umbrella clinical trial for patients with colon cancer that quickly identifies and targets emergent resistant traits through integration of drug response biomarkers and resistance-targeting drugs.